Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW6126 / 1||RA / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': IEPFIZER INC2021654698
Write-up: Fainted after vaccination; This is a spontaneous report from a contactable consumer (patient) received from Pfizer sponsored program. A 24-year-old male patient received first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration, administered in right arm, on 04Jun2021 at 13:30 (Lot number: EW6126, at the age of 24-year-old) as single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced fainted after vaccination on 04Jun2021 13:30. There were no treatment for the event. The outcome of the event was recovered on unspecified date in Jun2021.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166